Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer - Concepedia

Concepedia

Publication | Open Access

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

DOI Full Paper Access

161

Citations

28

References

2016

Year

Yvette Drew, Jonathan A. Ledermann, Geoff Hall, Daniel Rea, Rosalind Glasspool, Martin Highley, Gordon C. Jayson, Julieann Sludden, J. C. Murray, David Jamieson,

British Journal of Cancer

References

	Year	Citations

Page 1